Herabeat

HeraMed’s telehealth solutions address self-isolation needs

Finfeed Archived Mar 25, 2020

HeraMED Limited (ASX: HMD) has received a significant uplift in interest and demand for its proprietary in-home pregnancy monitoring products HeraBEAT and HeraCARE as communities go into self isolation.